Bullish
Is Wave Life Sciences (WVE) Undervalued On Its New Obesity Trial Progress?
Wave Life Sciences (WVE) has initiated the Phase 2a multidose part of its INLIGHT trial for obesity drug candidate WVE-007, following positive Phase 1...